admin | All Articles

admin
Contributor

Hickok Incorporated Reports Third Quarter and Nine Month Results

9:07 AM 08/13/2015

CLEVELAND, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Hickok Incorporated (Pink Sheets:HICKA), a Cleveland based supplier of products and services for the automotive, emissions testing, locomotive, and aircraft industries, today reported operating results for the third quarter and nine months ended June 30, 2015.

Hickok Incorporated Reports Third Quarter and Nine Month Results

9:07 AM 08/13/2015

CLEVELAND, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Hickok Incorporated (Pink Sheets:HICKA), a Cleveland based supplier of products and services for the automotive, emissions testing, locomotive, and aircraft industries, today reported operating results for the third quarter and nine months ended June 30, 2015.

Weibo Corporation to Report Second Quarter 2015 Financial Results on August 18, 2015

9:00 AM 08/13/2015

BEIJING, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Weibo Corporation (NASDAQ:WB), a leading social media for people to create, share and discover Chinese-language content, will announce its unaudited financial results for the second quarter of 2015 after the close of market on August 18, 2015. Following the announcement, Weibo's management team will host a conference call from 9 PM – 10 PM Eastern Time on August 18, 2015 (or 9 AM – 10 AM Beijing Time on August 19, 2015) to present an overview of the Company's financial performance and business operations.

Weibo Corporation to Report Second Quarter 2015 Financial Results on August 18, 2015

9:00 AM 08/13/2015

BEIJING, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Weibo Corporation (NASDAQ:WB), a leading social media for people to create, share and discover Chinese-language content, will announce its unaudited financial results for the second quarter of 2015 after the close of market on August 18, 2015. Following the announcement, Weibo's management team will host a conference call from 9 PM – 10 PM Eastern Time on August 18, 2015 (or 9 AM – 10 AM Beijing Time on August 19, 2015) to present an overview of the Company's financial performance and business operations.

BG Medicine Prices Underwritten Public Offering

8:35 AM 08/13/2015

WALTHAM, Mass., Aug. 13, 2015 (GLOBE NEWSWIRE) -- (NASDAQ:BGMD) BG Medicine, Inc., the developer of the BGM Galectin-3® Test, today announced the pricing of an underwritten public offering of its equity securities. Roth Capital Partners is acting as sole manager for the offering.

Neothetics Reports Second Quarter 2015 Financial Results

8:00 AM 08/13/2015

SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported financial results and business progress for the second quarter 2015.

Neothetics Reports Second Quarter 2015 Financial Results

8:00 AM 08/13/2015

SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported financial results and business progress for the second quarter 2015.

Foamix Pharmaceuticals Second Quarter 2015 Conference Call & Webcast Scheduled for Thursday, August 20

8:00 AM 08/13/2015

REHOVOT, Israel and BRIDGEWATER, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it will announce second quarter 2015 financial results and host a conference call and webcast on Thursday, August 20, 2015.

Foamix Pharmaceuticals Second Quarter 2015 Conference Call & Webcast Scheduled for Thursday, August 20

8:00 AM 08/13/2015

REHOVOT, Israel and BRIDGEWATER, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it will announce second quarter 2015 financial results and host a conference call and webcast on Thursday, August 20, 2015.

VBL Therapeutics Announces Second Quarter 2015 Financial Results and Provides Business Update

8:00 AM 08/13/2015

-- Reported Strengthened, Statistically Significant Interim Data From VB-111 Phase 2 Study in rGBM --
-- Reported Clinically Meaningful Interim Data From VB-111 Phase 1/2a Study in Platinum-Resistant Ovarian Cancer --
-- Presented Data on Proprietary Gene Therapy Vascular Targeting System™ --
-- Announces Successful Pre-Clinical Trial Application (CTA) Meeting With Health Canada --